{"nct_id":"NCT04495010","title":"Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants","status":"WITHDRAWN","status_verified_date":"2021-03","start_date":"2021-03-31","start_date_type":"ESTIMATED","primary_completion_date":"2024-02-28","primary_completion_date_type":"ESTIMATED","completion_date":"2027-10-23","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BMY"]}